Dengue virus infection and neurological manifestations: an update

• Published in: Brain (London, England : 1878) England : 1878), 2024-03, Vol.147 (3), p.830-838
• Main Authors: Fong, Si-Lei, Wong, Kum-Thong, Tan, Chong-Tin
• Format: Article
• Language: English
• ISSN: 0006-8950; 1460-2156
• DOI: 10.1093/brain/awad415

Dengue virus is a flavivirus transmitted by the mosquitoes, Aedes aegypti and Aedes albopictus. Dengue infection by all four serotypes (DEN 1 to 4) is endemic globally in regions with tropical and sub-tropical climates, with an estimated 100-400 million infections annually. Among those hospitalized, the mortality is about 1%. Neurological involvement has been reported to be about 5%. The spectrum of neurological manifestations spans both the peripheral and central nervous systems. These manifestations could possibly be categorised into those directly related to dengue infection, i.e. acute and chronic encephalitis, indirect complications leading to dengue encephalopathy, and post-infectious syndrome due to immune-mediated reactions, and manifestations with uncertain mechanisms such as acute transverse myelitis, acute cerebellitis, and myositis. The rising trend in global dengue incidence calls for attention to a more explicit definition of each neurological manifestation for more accurate epidemiological data. The actual global burden of dengue infection with neurological manifestation is essential for future planning and execution of strategies, especially in the development of effective antiviral and vaccines against the dengue virus. In this update, we discussed the recent findings of different spectrums of neurological manifestations in dengue infection and provided up-to-date antiviral and vaccine development and its challenges.